EP1986721A2 - Inhalateur - Google Patents

Inhalateur

Info

Publication number
EP1986721A2
EP1986721A2 EP07722848A EP07722848A EP1986721A2 EP 1986721 A2 EP1986721 A2 EP 1986721A2 EP 07722848 A EP07722848 A EP 07722848A EP 07722848 A EP07722848 A EP 07722848A EP 1986721 A2 EP1986721 A2 EP 1986721A2
Authority
EP
European Patent Office
Prior art keywords
blister
inhaler
blister strip
pockets
receiving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07722848A
Other languages
German (de)
English (en)
Inventor
Ralf Thoemmes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Vectura Delivery Devices Ltd
Original Assignee
Boehringer Ingelheim International GmbH
Vectura Delivery Devices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH, Vectura Delivery Devices Ltd filed Critical Boehringer Ingelheim International GmbH
Priority to EP07722848A priority Critical patent/EP1986721A2/fr
Publication of EP1986721A2 publication Critical patent/EP1986721A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A61M15/0036—Piercing means hollow piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0053—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal
    • A61M15/0055—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal the used dosages being coiled
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/07—General characteristics of the apparatus having air pumping means

Definitions

  • the present invention relates to an inhaler according to the preamble of one of the independent claims.
  • the present invention relates to an inhaler for dispensing a powdered inhalation formulation from a blister strip having a plurality of blister pockets each containing a dose of an inhalation formulation.
  • GB 2 407 042 A discloses an inhaler with a rolled-up blister strip.
  • one dose of the inhalation formulation is removed from each blister pocket, thereby emptying this blister pack.
  • This can be done inhalation, for example, by inhaling a patient in that an air flow through the previously pierced or otherwise opened blister pocket is generated, so that the inhalation formulation located in the blister pack mixes with the air and is output in the desired manner.
  • the emptied blister bags are each issued and must be disposed of.
  • WO 2005/037353 A1 discloses a similar inhaler, the part of the blister strip having already opened and / or emptied blister pockets - this part is also referred to in the present invention as "used
  • the present invention has for its object to provide an inhaler, the optimized storage of a used part of a blister strip with empty blister pockets and / or the separation of used and unused blister pockets or parts of the blister strip to prevent or reduce contamination allows.
  • a first aspect of the present invention is to wind the used part by spring force and / or to draw into a receiving space.
  • this is done with a arranged in the receiving space clock spring which engages the free end of the used part of the blister strip.
  • the inhaler preferably has a conveying device for stepwise advancement of the blister strip in order to be able to empty the blister pockets successively for inhaling the respective dose.
  • the conveying device is designed such that the blister strip can be moved stepwise in each case preferably exclusively by spring force to the next blister pocket niewegbar. This allows a simplification of the operation, since - in particular with purely mechanical construction of the inhaler - a complete further movement of the blister strip from a blister pack to the next blister pack by a user is not required. Rather, it is sufficient to release or trigger, which can be achieved, for example, with relatively little force and, if necessary, very short movement to release the blister strip, so that it is moved by the spring force to the next blister bag.
  • the used part of the blister strip is not drawn into a receiving space, but preferably only pushed into it.
  • the receiving space is preferably formed as a channel, which runs in particular helical or helical. It preferably has a small channel width, which corresponds in particular at least substantially to the radial thickness of the used part of the blister strip. It is thus easy to obtain positive guidance of the part used. In particular, the used part is then "wound up" helically when it is pushed into the channel.
  • a conveyor of the inhaler which is provided for the stepwise further movement of the blister strip, sufficient as the only drive and designed such that it on the one hand the still unused portion of the blister strip with not yet emptied blister pockets and on the other hand, the unused part in the receiving space or Channel slides.
  • the conveyor is then preferably arranged between a reservoir of the inhaler for the still unused part and the receiving space.
  • the inhaler has an additional device for compressing deflated blister pockets. This allows a substantial reduction in the required size of the receiving space for the used part of the blister strip, since the emptied blister pockets occupy a much smaller space after compression. Accordingly, the inhaler can be made particularly compact.
  • the conveyor and the receiving device simultaneously or sequentially, in particular by a common actuating element, for example by pivoting a lever operable.
  • the additional device is formed by the conveyor.
  • the receiving means is designed such that the used part of the blister strip is wound or bent in the same direction in which the still unused part of the blister strip, in particular in a reservoir, is wound or bent. This in turn allows a special - A -
  • the winding plane of the unused portion of the blister strip and the winding plane of the used part of the blister strip lie in a common plane.
  • the reservoir and the receiving space are arranged side by side. This allows in particular a minimization of the height or a particularly flat training PHg of the inhaler.
  • the winding plane of the unused part and the winding plane of the used part are superimposed.
  • the reservoir and the receiving space are arranged one above the other. In particular, this would allow a minimization of the areal extent of the inhaler.
  • the receiving space for the used part of the blister strip and the reservoir for the unused portion of the blister strip are separated from each other or separated from each other, in particular so that possibly in the opened and emptied blister pockets remaining remnants of the inhalation formulation - At least with normal use of the inhaler - do not reach the unused portion of the blister strip and can settle there, for example, undesirably outside. This could in fact lead to an inaccurate dosage, which can be excluded by the proposed separation, however.
  • Figure 1 is a schematic representation of a proposed inhaler according to a first embodiment in the open state with an already fully used blister strip.
  • 2 is a schematic representation of a proposed inhaler according to a second embodiment in the opened state with a still largely unused blister strip;
  • Fig. 3 is a schematic representation of a proposed inhaler according to a third embodiment, which is very similar to the first;
  • FIG. 4 is a schematic representation of a proposed inhaler according to a fourth embodiment, which is very similar to the second one.
  • FIG. 1 shows in a very schematic representation a proposed inhaler 1 according to a first embodiment, specifically in a cut-open state without lid or cover.
  • the inhaler 1 serves to dispense a preferably pulverulent inhalation formulation from a blister strip 2 with a multiplicity of blister pockets 3, each of which directly contains a dose of the in particular loose inhalation formulation.
  • the powder 4 forming the inhalation formulation is indicated by way of example in FIG. 1 in the case of a blister pocket 3.
  • preferably one dose of the inhalation formulation is taken from a blister pocket 3.
  • the blister strip 2 is preferably formed band-shaped. Preferably, the blister strip 2 is finally formed, so does not form an endless or closed loop.
  • the inhaler 1 preferably has a reservoir 5 for the still unused blister strip 2 with not yet emptied blister pockets 3.
  • the blister strip 3 is rolled up or wound up in the reservoir 5.
  • the reservoir 5 is formed so that the blister strip 2 can be moved out or pulled out as easily as possible.
  • no partitions or inner guides are provided in the illustrated example, but the reservoir 5 is limited here only by preferably continuous side walls and flat sides.
  • the winding or curvature plane of the unused blister strip 2-that is to say of the blister strip 2 in the reservoir 5- here corresponds to the plane of the drawing or a parallel plane.
  • the blister strip 2 is received directly in the reservoir 5.
  • a cassette, a container, a drum or the like can also be inserted with the blister strip 2 into the inhaler 1 or the reservoir 5.
  • the inhaler 1 has a mouthpiece 6 for a user, not shown.
  • the individual emptying of the blister pockets 3 is effected by a removal device 18, preferably with a piercing element A.
  • the removal device 18 is shown here only schematically and is preferably arranged adjacent to the mouthpiece 6.
  • the respective blister pocket 3 is obviously, for example, pierceable or sliceable.
  • the respective blister pocket 3 is obviously visible from the outside by means of the removal device 18, in that it is pierced or cut open by the piercing element A.
  • the respectively open blister pocket 3 is preferably emptied by suction.
  • An air flow L of ambient air is sucked in and conducted by the removal device 18 through the opened blister pocket 3 in such a way that the loose inhalation formulation with the intake ambient air is emitted as the aerosol cloud 17.
  • the inhaler 1 has a conveyor 7 for the stepwise advancement of the blister strip 2, preferably by a respective blister pocket 3, in order to be able to feed the blister pockets 3 successively to the removal device 18 for emptying and inhaling the respective dose.
  • the blister strip 2 is preferably deflected in the conveyor 7 at most by 90 °. This supports the desired ease of movement.
  • the conveyor 7 in the illustrated example, a drive wheel 8, which engage for example between the blister pockets 3 and so can promote the blister strip 2 form-fitting manner.
  • the conveyor 7 is preferably operated manually. Possible structural details follow in the description of the second embodiment.
  • the inhaler 1 has a receiving device 9, in particular with a receiving space 10 for receiving or storing the used part of the blister strip 2.
  • the receiving device 9 is formed in the first embodiment such that the blister strip 2 after use - ie after emptying of the individual blister pockets 3 - is slidable into the receiving space 10, in particular wherein the blister strip 2 or used part is received in a defined and compact manner ,
  • the receiving space 10 for example, with a guide, not shown, or the like. Be provided.
  • the receiving space 10 is particularly preferably provided with a channel or formed as a channel into which the blister strip 2 is slidable.
  • the blister strip 2 is already completely conveyed out of the reservoir 5 in the illustrated state and at least for the most part received by the receiving device 9 or its receiving space 10, in the illustration example pushed into the canal.
  • the channel preferably has the smallest possible channel width, which corresponds at least substantially to the radial thickness of the used part of the blister strip 2.
  • the channel preferably runs at least substantially spirally or helically.
  • the channel may meander and / or extend in another plane.
  • the receiving device 9 and in particular the inhaler 1 are preferably designed such that the used part of the blister strip 2 is wound or bent in the same direction, in which the still unused part of the blister strip 2 with not yet emptied blister pockets 3 in the inhaler 1 -. in particular in the reservoir 5 - recorded, in particular wound or bent.
  • the uniform winding or bending direction applies in particular for other areas in which the blister strip 2 is guided in the inhaler 1, so for example from the reservoir 5 to the receiving space 10, that is generally for the blister strip 2. Due to the uniform Biege, Winding direction of the blister strip 2, it is easier, the blister strip 2 - so the used part - as narrow and compact to bend or wik- no, so the receiving space 10 as small as possible and space-saving form. Furthermore, there are much lower conveying forces and thus ease of operation of the inhaler 1, when the blister strip 2 must be bent by a certain radius and was not previously bent in the opposite direction.
  • the conveyor 7 is sufficiently strong dimensioned in the representation example to push the used part of the blister strip 2 in the channel can.
  • the blister strip 2 is therefore moved further forward or forward exclusively by the conveyor 7.
  • the inhaler 1 only a single conveyor 7. This allows a simple and therefore cost-effective design of the inhaler 1 of a few components.
  • the conveying device 7 is preferably arranged between the reservoir 5 and the receiving device 9, in particular between the removal device and the receiving space 10, that is to say after the blister pockets 3 have been emptied.
  • the receiving space 10 is preferably separated from the reservoir 5, in the illustrated example in particular by the continuous partition 1 1. In this way can be prevented or at least minimized be that any residues of the inhalation formulation from the already emptied and opened blister pockets 3 fall out and can attach outside of the blister strip 2 in the region of the unused part, so still filled blister pockets 3.
  • the separation of the receiving space 10 thus prevents or at least minimizes a possible contamination or incorrect dosage by said residues.
  • FIG. 2 corresponds at least essentially to the representation according to FIG.
  • FIG. 2 corresponds at least essentially to the representation according to FIG.
  • only essential differences of the second embodiment compared to the first embodiment will be explained to avoid repetition.
  • the previous statements and explanations to the first embodiment and generally to the present invention thus apply correspondingly or in addition.
  • the inhaler 1 or the suction device 9 is designed such that the used part of the blister strip 2 is wound up by spring force and / or pulled into the receiving space 10.
  • the conveyor 9 preferably has a spring, in particular a clock spring 12, which is shown only schematically in FIG. 2 in the tensioned state.
  • the spring is arranged in the representation example in the receiving space 10 and preferably engages the free end of the used part of the blister strip 2.
  • the spring 2 is suspended at the end region in the blister strip 2.
  • the tension or tensile force of the spring ie the spring force, is sufficiently high around the blister strip
  • the conveyor 7 is then preferably designed such that the blister strip 2 can be gradually released and in each case preferably only by the spring force to the next blister pocket 3 is moved on.
  • This allows a particularly simple operation and handling of the inhaler 1, since then only an unlock or release, for example by pressing a button, not shown, must be effected by a user, not shown.
  • incomplete forwarding of the blister strip 2 from one blister pocket 3 to the next blister pocket 3 in the event of improper use can be ruled out.
  • the conveyor 7 is preferably formed, however, such that an actuating element, in particular a hand lever 13, must be pivoted by a user, not shown, to turn the drive wheel 8 step by step and thereby further promote the blister strip 2 by one step.
  • the drive wheel 8 or the conveyor 7 is preferably provided with a freewheel and a corresponding turnstile, so that the drive wheel 8 when swinging back and forth and also in an incomplete pivoting of the hand Hebeis 13 in the desired manner only in one direction and in particular only in the desired steps is rotatable.
  • the inhaler 1 preferably has an additional device 14 for squeezing emptied blister pockets 3.
  • the additional device 14 allows compressed blister pockets 3 to be compressed before the respective receptacle is received in the receiving space 10. Compression takes place in particular after the conveyor 7 or the conveyor wheel 8 and before the receiving space 10.
  • the additional device 14 is coupled to the conveyor 7 or formed by this.
  • the cooperation men briefly a deflated blister pocket 3 preferably immediately after the further promotion of the blister strip 2 by one step, ie the next still filled blister pocket 3.
  • the additional device 14 with the actuating element of the conveyor 7, in particular so the hand lever 13 coupled.
  • the additional device 14 is formed by an extension 15 of the hand lever 13, the compression of a deflated blister pocket 3 causes complete pivoting of the hand lever 13 by the respective blister pocket 3 between the extension 15, which is provided with a corresponding contact surface, and a fixed in the representation example abutment surface 16 is clamped. Due to a corresponding leverage so a very effective compression of the emptied blister pockets 3 can be achieved. As a result, the blister strip 2 can then be wound up substantially more compactly by the receiving device 9-in the illustrated example by the watch spring 12-than by the blister pockets 3 which are not compressed.
  • a cloud 17 in FIG. 2 schematically indicates how the inhalation formulation during inhalation or atomization could be output by the inhaler 1.
  • the inhalation formulation is discharged from the respective blister pocket 3 by gas or air under pressure. It is then an active inhaler 1; the preferably pulverulent, but possibly also liquid inhalation formulation is thus actively atomized or dispensed, and not by an air stream generated by inhalation during inhalation.
  • the inhaler 1 or the removal device 18 has a device 19 for providing pressurized gas.
  • This may be, for example, a gas reservoir for compressed and / or liquefied gas or an example manually operable air pump.
  • the removal device 18 has, for example, a schematically indicated supply line 20 in order to be able to supply the pressurized gas, in particular air, from the device 19 to the respective or opened blister pocket 3.
  • the pressurized gas is directed into the blister pocket 3 to dispense and atomize the inhalation formulation, in particular to form an inhalable mixture of inhalation formulation and gas or air to produce an aerosol cloud 17.
  • the inhalation formulation from an opened blister pocket 3 may initially be required in a flow path, for example by gravity, vibration or the like, in order then to be discharged by the pressurized gas and to be atomized.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne un inhalateur destiné à délivrer une formulation poudreuse d'inhalation d'un ruban de poches qui présente plusieurs poches. La partie utilisée du ruban de poches, qui présente des poches vides, est enroulée par un ressort en spirale ou enfoncée dans un canal en spirale, ce qui permet une structure simple, les rubans de poches épuisés étant séparés de la partie encore non utilisée.
EP07722848A 2006-02-20 2007-02-19 Inhalateur Withdrawn EP1986721A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07722848A EP1986721A2 (fr) 2006-02-20 2007-02-19 Inhalateur

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06003367 2006-02-20
EP06003368 2006-02-20
EP07722848A EP1986721A2 (fr) 2006-02-20 2007-02-19 Inhalateur
PCT/EP2007/001411 WO2007096111A2 (fr) 2006-02-20 2007-02-19 Inhalateur

Publications (1)

Publication Number Publication Date
EP1986721A2 true EP1986721A2 (fr) 2008-11-05

Family

ID=38066553

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07722848A Withdrawn EP1986721A2 (fr) 2006-02-20 2007-02-19 Inhalateur

Country Status (11)

Country Link
US (1) US20100139654A1 (fr)
EP (1) EP1986721A2 (fr)
JP (1) JP2009527264A (fr)
KR (1) KR20080108995A (fr)
AU (1) AU2007218261B2 (fr)
BR (1) BRPI0708109A2 (fr)
CA (1) CA2642745A1 (fr)
MX (1) MX2008009325A (fr)
NO (1) NO20083487L (fr)
SG (1) SG170003A1 (fr)
WO (1) WO2007096111A2 (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8371294B2 (en) 2008-02-29 2013-02-12 Microdose Therapeutx, Inc. Method and apparatus for driving a transducer of an inhalation device
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US8474452B2 (en) 2004-02-24 2013-07-02 Microdose Therapeutx, Inc. Directional flow sensor inhaler
US8573202B2 (en) 2000-06-28 2013-11-05 Microdose Therapeutx, Inc. Packaging and delivery of pharmaceuticals and drugs
US8748488B2 (en) 2008-05-30 2014-06-10 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8763606B2 (en) 2009-05-21 2014-07-01 Microdose Therapeutx, Inc. Rotary cassette system for dry powder inhaler
US8985101B2 (en) 2009-05-21 2015-03-24 Microdose Therapeutx, Inc. Method and device for clamping a blister within a dry powder inhaler
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US10238821B2 (en) 2016-10-11 2019-03-26 Microdose Therapeutx, Inc. Inhaler and methods of use thereof

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008081132A2 (fr) * 2006-12-11 2008-07-10 Valois Sas Dispositif de distribution de produit fluide
FR2918353B1 (fr) * 2007-07-03 2009-10-09 Valois Sas Dispositif de distribution de produit fluide
FR2918354B1 (fr) 2007-07-03 2009-10-09 Valois Sas Dispositif de distribution de produit fluide
US20100252032A1 (en) * 2007-07-06 2010-10-07 Boehringer Ingelheim International Gmbh Inhaler
EP2011536A1 (fr) 2007-07-06 2009-01-07 Boehringer Ingelheim Pharma GmbH & Co. KG Inhalateur
ES2569359T3 (es) * 2007-07-06 2016-05-10 Vectura Delivery Devices Limited Inhalador
EP2011537A1 (fr) * 2007-07-06 2009-01-07 Vectura Delivery Devices Limited Inhalateur
FR2924355B1 (fr) * 2007-12-03 2010-01-29 Valois Sas Dispositif de distribution de produit fluide.
CA2709071C (fr) 2007-12-14 2016-11-15 Labogroup S.A.S. Administration de produits alimentaires sous forme d'aerosols
EP2082765A1 (fr) 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhalateur
EP2082766A1 (fr) * 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Formation d'une spirale de bande alvéolée
EP2082758A1 (fr) 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhalateur
EP2082759A1 (fr) * 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhalateur
EP2082767A1 (fr) * 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhalateur
EP2082770A1 (fr) * 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhalateur
EP2082771A1 (fr) * 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhalateur
EP2082762A1 (fr) * 2008-01-24 2009-07-29 Boehringer Ingelheim International Gmbh Inhalateur
EP2082764A1 (fr) * 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhalateur
EP2082763A1 (fr) * 2008-01-24 2009-07-29 Boehringer Ingelheim International Gmbh Inhalateur
US20110000481A1 (en) * 2009-07-01 2011-01-06 Anand Gumaste Nebulizer for infants and respiratory compromised patients
EP2277576A1 (fr) * 2009-07-24 2011-01-26 Vectura Delivery Devices Limited Inhalateur
EP2662105B1 (fr) 2012-05-09 2017-01-18 Boehringer Ingelheim International GmbH Pulvérisateur
WO2015049611A1 (fr) * 2013-10-01 2015-04-09 Novartis Ag Dispositif d'inhalateur à piste de bande alvéolaire comportant un circuit d'extrémité séparé, et procédés d'utilisation de ce dispositif
EP3325059B1 (fr) * 2015-07-20 2021-02-17 Vectura Delivery Devices Limited Inhalateur de poudre sèche
EP3852849B1 (fr) * 2018-09-17 2022-06-29 Vectura Delivery Devices Limited Inhalateur de poudre sèche

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2351396A (en) * 1941-01-08 1944-06-13 Broms Allan Film developing tank and method
US4733797A (en) * 1986-09-22 1988-03-29 Haber Terry M Dosage sealing, monitoring and dispensing assembly
US4763810A (en) * 1986-12-19 1988-08-16 Christiansen Lee T Medication dispenser
GB8909891D0 (en) * 1989-04-28 1989-06-14 Riker Laboratories Inc Device
AU643435B2 (en) * 1989-04-28 1993-11-18 Riker Laboratories, Inc. Dry powder inhalation device
US5110008A (en) * 1989-09-29 1992-05-05 Moulding Jr Thomas S Dispenser adapted to isolate the dispensed objects by compression between two moveable structures
UA26230A (uk) * 1990-03-02 1999-07-19 Глексо Груп Лімітед Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок
FR2667509B1 (fr) * 1990-10-04 1995-08-25 Valois Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
CZ289029B6 (cs) * 1994-09-21 2001-10-17 Inhale Therapeutic Systems Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu
US6752148B1 (en) * 1999-02-10 2004-06-22 Delsys Pharmaceutical Company Medicament dry powder inhaler dispensing device
ES2225246T3 (es) * 1999-10-12 2005-03-16 Shl Medical Ab Inhalador.
GB0125135D0 (en) * 2001-10-19 2001-12-12 Glaxo Group Ltd Medicament dispenser
GB0201677D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
GB2407042B (en) * 2003-10-17 2007-10-24 Vectura Ltd Inhaler

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007096111A2 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8573202B2 (en) 2000-06-28 2013-11-05 Microdose Therapeutx, Inc. Packaging and delivery of pharmaceuticals and drugs
US9162031B2 (en) 2004-02-24 2015-10-20 Microdose Therapeutx, Inc. Directional flow sensor inhaler
US9764104B2 (en) 2004-02-24 2017-09-19 Microdose Therapeutx, Inc. Directional flow sensor inhaler
US8474452B2 (en) 2004-02-24 2013-07-02 Microdose Therapeutx, Inc. Directional flow sensor inhaler
US9132246B2 (en) 2007-10-09 2015-09-15 Microdose Therapeutx, Inc. Inhalation device
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US8371294B2 (en) 2008-02-29 2013-02-12 Microdose Therapeutx, Inc. Method and apparatus for driving a transducer of an inhalation device
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8748488B2 (en) 2008-05-30 2014-06-10 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8763606B2 (en) 2009-05-21 2014-07-01 Microdose Therapeutx, Inc. Rotary cassette system for dry powder inhaler
US8985101B2 (en) 2009-05-21 2015-03-24 Microdose Therapeutx, Inc. Method and device for clamping a blister within a dry powder inhaler
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method
US9974909B2 (en) 2010-01-05 2018-05-22 Microdose Therapeutx, Inc. Inhalation device and method
US10434267B2 (en) 2010-01-05 2019-10-08 Microdose Therapeutx, Inc. Inhalation device and method
US10238821B2 (en) 2016-10-11 2019-03-26 Microdose Therapeutx, Inc. Inhaler and methods of use thereof

Also Published As

Publication number Publication date
AU2007218261A1 (en) 2007-08-30
WO2007096111A3 (fr) 2007-11-08
US20100139654A1 (en) 2010-06-10
JP2009527264A (ja) 2009-07-30
AU2007218261B2 (en) 2013-03-28
WO2007096111A2 (fr) 2007-08-30
MX2008009325A (es) 2008-12-18
CA2642745A1 (fr) 2007-08-30
BRPI0708109A2 (pt) 2011-05-17
NO20083487L (no) 2008-09-22
SG170003A1 (en) 2011-04-29
KR20080108995A (ko) 2008-12-16

Similar Documents

Publication Publication Date Title
WO2007096111A2 (fr) Inhalateur
DE69333554T2 (de) Pulverinhalator
EP0545960B1 (fr) Inhalateur sans gaz propulseur
EP0530625B1 (fr) Distributeur de fluides
DE4106379C2 (de) Inhalationsgerät und Medikamentenpackung hierfür
DE60020715T2 (de) Inhaliervorrichtung
DE60115480T2 (de) Inhalationsgerät
DE4436051C2 (de) Vorrichtung zum Betätigen von Aerosolabgabegeräten
DE102006023662A1 (de) Inhalator
DE10011120A1 (de) Spender für Medien
DE1917911B2 (de) Inhalationsgeraet
WO1991012040A1 (fr) Inhalateur de poudres
DE19708406A1 (de) Gerät zur dosierten Ausgabe von Substanzen
EP0667793A1 (fr) Procede et dispositif permettant de produire un aerosol a partir d'une substance pulverulente.
WO1992004068A1 (fr) Inhalateur sans gaz propulseur a courant d'air exterieur
EP1905471A2 (fr) Dispositif d'inhalation
WO2005089842A1 (fr) Inhalateur, en particulier inhalateur de medicaments en poudre
DE102006006647B3 (de) Vorrichtung zum Inhalieren eines in einer Kapsel sich befindenden Pulvers
DE69907039T2 (de) Biegsamer antriebsmechanismus sowie abgabevorrichtung enthaltend einen solchen mechanismus
EP3402372A1 (fr) Distributeur
EP2662105A1 (fr) Pulvérisateur
EP1898764A1 (fr) Distributeur de dentifrice commande a une main
DE2934732C2 (de) Dosiereinrichtung für Inhalate
DE404283C (de) Abteilvorrichtung fuer Tabakwickel
DE202009006141U1 (de) Inhalator

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080714

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1117438

Country of ref document: HK

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MOCK ELMAR

Inventor name: TIMO VON BRUNN C/O BOEHRINGER INGELHEIM GMBH CD P

Inventor name: THOEMMES, RALF

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20131210

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1117438

Country of ref document: HK